SlicerPETDenoise is a 3D Slicer extension that includes three modules intended for medical image research, particularly PET and CT image workflows. These modules assist in denoising, comparing, and ...
ATLANTA - Artivion, Inc. (NYSE:AORT), a $1.93 billion market cap medical device company whose shares have surged 31.86% over the past six months, announced new clinical data from two trials evaluating ...
ATLANTA, Feb. 2, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the presentation of new clinical data from ...
1-Year Data from Endospan's NEXUS TRIOMPHE IDE Trial Demonstrate High Patient Survival with Low Morbidity 2-Year Data from the AMDS PERSEVERE IDE Trial Further Demonstrate the Persistent Clinical ...
At FDA's request, Type D Meeting expected in March 2026 to review Comparative Oncology biomarker data from patients treated in OST-HER2 Phase 2b human clinical trial and OST-HER2 trial in spontaneous ...
New York, New York--(Newsfile Corp. - February 2, 2026) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in listeria-based cancer immunotherapies, today ...
Abstract: This study was conducted according to the British Standard EN ISO 81060-2 guidelines. The aim was to validate the Saadat non-invasive blood pressure (NIBP) module accuracy and reliability ...
New eTMF module integrates with Enlighten Clinical Solutions’ platform to support inspection-ready clinical trial documentation and execution. ATLANTA, GA, UNITED ...
Investing.com - Barclays has maintained its Overweight rating on Ultragenyx Pharmaceutical (NASDAQ:RARE) with a price target of $44.00, representing nearly 79% upside from the current price of $24.61.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results